|
Volumn 9, Issue 3, 2007, Pages 168-178
|
Effects of valsartan or amlodipine alone or in combination on plasma catecholamine levels at rest and during standing in hypertensive patients.
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMLODIPINE;
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTIHYPERTENSIVE AGENT;
BIOLOGICAL MARKER;
CATECHOLAMINE;
DRUG DERIVATIVE;
TETRAZOLE DERIVATIVE;
VALINE;
VALSARTAN;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
BLOOD;
BLOOD PRESSURE;
BODY POSTURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG COMBINATION;
DRUG EFFECT;
FEMALE;
HEART RATE;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
HYPERTENSION;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
REST;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
AGED;
AMLODIPINE;
ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS;
ANTIHYPERTENSIVE AGENTS;
BIOLOGICAL MARKERS;
BLOOD PRESSURE;
CATECHOLAMINES;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
DRUG THERAPY, COMBINATION;
FEMALE;
HEART RATE;
HUMANS;
HYPERTENSION;
MALE;
MIDDLE AGED;
POSTURE;
REST;
TETRAZOLES;
TREATMENT OUTCOME;
VALINE;
|
EID: 34247263709
PISSN: 15246175
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1524-6175.2007.05938.x Document Type: Article |
Times cited : (28)
|
References (0)
|